IE38655B1 - Pharmaceutical compositions for treating spasticity - Google Patents
Pharmaceutical compositions for treating spasticityInfo
- Publication number
- IE38655B1 IE38655B1 IE2267/73A IE226773A IE38655B1 IE 38655 B1 IE38655 B1 IE 38655B1 IE 2267/73 A IE2267/73 A IE 2267/73A IE 226773 A IE226773 A IE 226773A IE 38655 B1 IE38655 B1 IE 38655B1
- Authority
- IE
- Ireland
- Prior art keywords
- hydroxy
- dihydroxyphenyl
- butylaminoethane
- tert
- isopropylaminoethane
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
1453034 Skeletal muscle relaxing preparations BOEHRINGER INGELHEIM GmbH 14 Dec 1973 [15 Dec 1972] 58088/72 Heading A5B . A pharmaceutical composition for use in the treatment of spastically disabled human being comprises a sympathomimetic amine or a physiologically acceptable salt thereof together with an effective amount of sustained or delayed release agent, said amine being: 1-(3, 5-dihydroxyphenyl)-1 -hydroxy-2-isopropylaminoethane; 1-(4-amino-3, 5-dichlorophenyl) - 1 -hydroxy-2-tert-butylaminoethane; 1-(3-hydroxymethyl -4- hydroxyphenyl) -1- hydroxy -2- tert butylaminoethane; 1-(3, 5 - dihydroxyphenyl) -1- hydroxy -2- (1-(4-hydroxybenzyl) ethyl)-aminoethane; 1-(3, 5-dihydroxyphenyl)- 1 -hydroxy-2-tert butylaminoethane; N, N'-bis- [1-(3, 4-dihydroxyphenyl)-1-hydroxyethyl (2)]- hexamethylenediamine; 1-(3, 4-dihydroxyphenyl)-1 -hydroxy-2-isopropylaminoethane; 2-[(3, 4-dihydroxyphenyl) hydroxymethyl] piperidinium hydrobromide; 8-hydroxy-5-( 1 -hydroxy-2- isopropylaminoethyl) quinoline; 1-diphenylmethyl-4-hydroxyethoxyethyl-piperazine; 1 -phenethylpiperidine-4-spiro-5'-[1', 3']-oxazolidin-2'- one; and 1-(2-phenyl-2-methoxyethyl)-4-(3-hydroxy-3-phenylpropyl) piperazine. The composition may be in a form suitable for oral or parenteral administration.
[GB1453034A]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5808872A GB1453034A (en) | 1972-12-15 | 1972-12-15 | Pharmaceutical composition for treating spasticity |
Publications (2)
Publication Number | Publication Date |
---|---|
IE38655L IE38655L (en) | 1974-06-15 |
IE38655B1 true IE38655B1 (en) | 1978-05-10 |
Family
ID=10480743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE2267/73A IE38655B1 (en) | 1972-12-15 | 1973-12-14 | Pharmaceutical compositions for treating spasticity |
Country Status (6)
Country | Link |
---|---|
BE (1) | BE808662A (en) |
DE (1) | DE2362123A1 (en) |
GB (1) | GB1453034A (en) |
IE (1) | IE38655B1 (en) |
IL (1) | IL43820A (en) |
ZA (1) | ZA739480B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1574894A (en) * | 1977-06-02 | 1980-09-10 | Nippon Kayaku Kk | Derivative of a-methyl-aminopropiophenone and use thereof |
DE2929456A1 (en) * | 1979-07-20 | 1981-02-05 | Lentia Gmbh | COMPOSITION WITH EXTENDED BRONCHOLYTIC AND TOCOLYTIC EFFECTIVENESS, A METHOD FOR THE PRODUCTION THEREOF AND BRONCHOLYTIC AND TOKOLYTICALLY ACTIVE AGENT |
CH656308A5 (en) * | 1982-05-27 | 1986-06-30 | Glaxo Group Ltd | PHARMACEUTICAL COMPOSITIONS CONTAINING SALBUTAMOL. |
US5468501A (en) * | 1982-09-01 | 1995-11-21 | Hercon Laboratories Corporation | Article useful for administration of pharmacologically-active substances transdermally, orally or by means of implant |
US5310559A (en) * | 1982-09-01 | 1994-05-10 | Hercon Laboratories Corporation | Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer |
US4525359A (en) * | 1982-12-10 | 1985-06-25 | Greenway Frank L Iii | Treatment for selective weight control |
JPS6061523A (en) * | 1983-09-16 | 1985-04-09 | Shionogi & Co Ltd | Oral dobutamine pharmaceutical |
US4751071A (en) * | 1983-12-01 | 1988-06-14 | Alza Corporation | Composition comprising salbutamol |
US4777049A (en) * | 1983-12-01 | 1988-10-11 | Alza Corporation | Constant release system with pulsed release |
US4851229A (en) * | 1983-12-01 | 1989-07-25 | Alza Corporation | Composition comprising a therapeutic agent and a modulating agent |
EP0251425B1 (en) * | 1986-04-03 | 1993-06-16 | Hercon Laboratories Corporation | Article for administration of pharmacologically-active substances |
-
1972
- 1972-12-15 GB GB5808872A patent/GB1453034A/en not_active Expired
-
1973
- 1973-12-14 IE IE2267/73A patent/IE38655B1/en unknown
- 1973-12-14 BE BE138890A patent/BE808662A/en unknown
- 1973-12-14 ZA ZA00739480*DA patent/ZA739480B/en unknown
- 1973-12-14 IL IL43820A patent/IL43820A/en unknown
- 1973-12-14 DE DE2362123A patent/DE2362123A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
GB1453034A (en) | 1976-10-20 |
IL43820A0 (en) | 1974-03-14 |
IL43820A (en) | 1977-08-31 |
BE808662A (en) | 1974-06-14 |
ZA739480B (en) | 1975-08-27 |
DE2362123A1 (en) | 1974-06-20 |
IE38655L (en) | 1974-06-15 |
AU6364773A (en) | 1975-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI945621A0 (en) | Regulated release formulation | |
GB2254784B (en) | Film-coated solid dosage form of anti-migraine drug | |
EP0221041A3 (en) | Benzimidazole derivatives, process for their preparation and their pharmaceutical use | |
CZ176495A3 (en) | The use of riluzol for preparing a medicament suitable for treating parkinson's disease and parkinson's syndromes | |
GEP20043324B (en) | Purine Derivatives | |
IE38655B1 (en) | Pharmaceutical compositions for treating spasticity | |
RU93032613A (en) | PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF PATIENTS WITH PROLONGED COAGULATION TIME, METHOD OF TREATING PATIENTS, USING THE EPI INHIBITOR FOR OBTAINING THE PHARMACEUTICAL PREPARATION | |
MY124465A (en) | Reduction of infarct volume using citicoline | |
KR900014406A (en) | Cefem compound and preparation method thereof | |
MY129946A (en) | Compound with gastric acid inhibitory effect and process for its preparation. | |
GB1487334A (en) | Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof | |
TR200103144T2 (en) | New compounds | |
GB2209281B (en) | Pharmaceutical compositions comprising an alpha-2 adrenoceptor antagonist | |
BR0011880A (en) | Method for the treatment of co-morbid conditions associated with obesity, compound, product, use of a compound, and pharmaceutical composition | |
DE59205998D1 (en) | Medicament with antineoplastic activity containing octadecyl- [2- (N-methylpiperidino) ethyl] phosphate as active ingredient and process for its preparation | |
KR930702985A (en) | Treatment of Esophageal Cancer | |
EP0613375A4 (en) | Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof. | |
IE37288B1 (en) | Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children | |
GEP20033054B (en) | 2,4,4-Trisubstituted-1,3-Dioxolane Antifungals | |
KR890701111A (en) | Treatment of dyslipidemia in humans | |
GB1375806A (en) | ||
Muntaner et al. | Effects of Nifedipine (A Ca++ Modulator) Pre-treatment on Cardio-vascular and Subjective Responses to Intravenous Cocaine Administration in Humans | |
CZ176395A3 (en) | The use of riluzol for preparing medicaments acceptable as antidotes against harmful effects of irradiation | |
JO1664B1 (en) | Compomnd with gastric acid inhibitory effect and process for its preparation | |
IT1271354B (en) | Preparation of a pharmaceutical form capable of combating hyperinsulinism |